×
NewGenIvf Group Price/Book Ratio 2023-2024 | NIVF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
NewGenIvf Group price/book ratio from 2023 to 2024. Price/book ratio can be defined as
View More
NewGenIvf Group Price/Book Ratio 2023-2024 | NIVF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
NewGenIvf Group price/book ratio from 2023 to 2024. Price/book ratio can be defined as
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
CVS Health (CVS)
$75.9B
Elevance Health (ELV)
$65B
Cencora (COR)
$56.2B
DiDi Global (DIDIY)
$25.7B
Labcorp Holdings (LH)
$21.9B
Natera (NTRA)
$18.5B
BioMerieux (BMXMF)
$17.1B
EUROFINS SCIENT (ERFSF)
$15.2B
ICON (ICLR)
$15B
CochLear (CHEOY)
$13.6B
Solventum (SOLV)
$12.7B
Medpace Holdings (MEDP)
$12.6B
Revvity (RVTY)
$11.1B
Viatris (VTRS)
$10.8B
Avantor (AVTR)
$9.5B
Sonic Healthcare (SKHHY)
$9.1B
Charles River Laboratories (CRL)
$8.8B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$7B
Bausch + Lomb (BLCO)
$5.2B
Amplifon S.p.A (AMFPF)
$5.1B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.4B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.6B
GeneDx Holdings (WGS)
$2.6B
Concentras Parent (CON)
$2.6B
Alignment Healthcare (ALHC)
$2.3B
Progyny (PGNY)
$2B